Advertisement

Health Before Patents: Challenging the Primacy of Intellectual Property Rights

  • Klaus Dieter Wolf
  • Saskia Scholz
Chapter
Part of the Global Issues book series (GLOISS)

Abstract

This chapter examines the conflict between international patent protection and the right to health. A successful campaign was waged by emerging nations and their civil society allies against the rules governing the protection of intellectual property as defined by the 1994 Agreement on Trade-Related Aspects of Intellectual Property Rights (TRIPS). Following this confrontation, a change of the TRIPS regime was agreed at the World Trade Organization’s 2001 Ministerial Conference in Doha. Since then, world trade rules have accorded the right to health precedence over the right to intellectual property. The human immunodeficiency virus crisis, the mobilising potential of non-governmental organisations, and rising powers such as India and Brazil as well as a new normative discourse, not least in the West, contributed to this change in global health politics.

Keywords

World Trade Organization Acquire Immune Deficiency Syndrome Patent Protection Intellectual Property Right Essential Medicine 
These keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.

References

  1. Brazil. 2009. ‘Statement by Brazil at TRIPS Council: Public Health Dimension of TRIPS Agreement’. Accessed 30 March 2015. http://keionline.org/blogs/2009/03/04/brazilian-intervention-at-trips-council.
  2. Bright, Keren, and Lois Muraguri. 2011. ‘Access to Medicines: Intellectual Property Rights, Human Rights and Justice’. In The Business of Human Rights: An Evolving Agenda for Corporate Responsibility, edited by Aurora Voiculescu and Helen Yanacopulos, 101–21. London: Zed Books.Google Scholar
  3. Carolan, Michael S. 2008. ‘Making Patents and Intellectual Property Work: The Asymmetrical ‘Harmonization’ of TRIPS’. Organization & Environment 21(3): 295–310.CrossRefGoogle Scholar
  4. CSN BRICSAM. n.d. ‘Tackling Inequalities in Access to Healthcare: Will the G20 Take up Global Leadership?’. Accessed 15 January 2015. http://csnbricsam.org/tackling-inequalities-in-access-to-healthcare-will-the-g20-take-up-global-leadership/.
  5. Cullet, Philippe. 2007. ‘Human Rights and Intellectual Property Protection in the TRIPS Era’. Human Rights Quarterly 29(2): 403–30.CrossRefGoogle Scholar
  6. Dreyfuss, Rochelle C. 2010. ‘TRIPS and Essential Medicines: Must One Size Fit All? Making the WTO Responsive to the Global Health Crisis’. In Incentives for Global Public Health: Patent Law and Access to Essential Medicines, edited by Thomas Pogge, Matthew Rimmer, and Kim Rubenstein, 35–55. Cambridge: Cambridge University Press.CrossRefGoogle Scholar
  7. European Commission. 2014. ‘President Barroso Attends 5th World Health Summit in Berlin’. Accessed 20 January 2015. http://ec.europa.eu/archives/commission_2010-2014/president/news/archives/2013/10/20131021_1_en.htm.
  8. Finnemore, Martha, and Kathryn Sikkink. 1998. ‘International Norm Dynamics and Political Change’. International Organization 52(4): 887–917.CrossRefGoogle Scholar
  9. Fischer-Lescano, Andreas, and Gunther Teubner. 2006. Regime-Kollisionen: Zur Fragmentierung des globalen Rechts. Frankfurt am Main: Suhrkamp Verlag.Google Scholar
  10. Florini, Ann M. 1996. ‘The Evolution of International Norms’. International Studies Quarterly 40(3): 363–89.CrossRefGoogle Scholar
  11. Ford, Nathan. 2004. ‘Patents, Access to Medicines and the Role of Non-Governmental Organisations’. Journal of Generic Medicines 1(2): 137–45.CrossRefGoogle Scholar
  12. Ford, Nathan, David Wilson, Onanong Bunjumnong, Schoen Angerer, and Tido Von. 2004. ‘The Role of Civil Society in Protecting Public Health over Commercial Interests: Lessons from Thailand’. The Lancet 363: 560–3.CrossRefGoogle Scholar
  13. Forman, Lisa. 2007. ‘Trade Rules, Intellectual Property, and the Right to Health’. Ethics & International Affairs 21(3): 337–57.CrossRefGoogle Scholar
  14. Grover, Anand, and Fiona Lander. 2012. ‘Das Recht auf Gesundheit in Theorie und Praxis’. Vereinte Nationen 5/2012: 214–8. Accessed 14 June 2016. http://www.dgvn.de/fileadmin/publications/PDFs/Zeitschrift_VN/VN_2012/Heft_5_2012/06_grover_lander_VN_5-12_10-10-2012.pdf.
  15. Hein, Wolfgang, and Lars Kohlmorgen. 2008. ‘Global Health Governance: Conflicts on Global Social Rights’. Global Social Policy 8(1): 80–108.CrossRefGoogle Scholar
  16. Hein, Wolfgang, and Suerie Moon. 2013. Informal Norms in Global Governance: Human Rights, Intellectual Property Rules and Access to Medicines. Aldershot: Ashgate.Google Scholar
  17. HRC. 2011. ‘Resolution Adopted by the Human Rights Council (HRC/RES/17/14): The Right of Everyone to the Enjoyment of the Highest Attainable Standard of Physical and Mental Health in the Context of Development and Access to Medicines’. Accessed 17 February 2015. https://documents-dds-ny.un.org/doc/UNDOC/GEN/G11/148/54/PDF/G1114854.pdf.
  18. India Department of Commerce. 2001. ‘India Seeks Flexibility in Interpretation of TRIPS Agreement to Ensure Affordable Access to Medicines and Life Saving Drugs’. Accessed 27 January 2015. http://commerce.nic.in/pressrelease/pressrelease_detail.asp?id=510.
  19. Joseph, Sarah. 2003. ‘Pharmaceutical Corporations and Access to Drugs: The “Fourth Wave” of Corporate Human Rights Scrutiny’. Human Rights Quarterly 25(2): 425–52.CrossRefGoogle Scholar
  20. Keck, Margaret E., and Kathryn Sikkink. 1998. Activists Beyond Borders. Ithaca, NY: Cornell University Press.Google Scholar
  21. Kirton, John J. 2013. G20 Governance for a Globalized World. Farnham: Ashgate.Google Scholar
  22. Klug, Heinz. 2008. ‘Law, Politics, and Access to Essential Medicines in Developing Countries’. Politics & Society 36(2): 207–46.CrossRefGoogle Scholar
  23. Maskus, Keith E. 2000. Intellectual Property Rights in the Global Economy. Washington, DC: Peterson Institute for International Economics.Google Scholar
  24. McCoy, David, and Margaret Hilson. 2009. ‘Civil Society, Its Organizations, and Global Health Governance’. In Making Sense of Global Health Governance: A Policy Perspective, edited by Kent Buse, Wolfgang Hein, and Nick Drager, 209–31. Houndmills: Palgrave Macmillan.Google Scholar
  25. MSF. 2011a. ‘Trips, Trips Plus and Doha’. Accessed 20 January 2015. http://www.msfaccess.org/content/trips-trips-plus-and-doha.
  26. MSF. 2011b. ‘G20 Leaders Should Bail Out Global Health With a Financial Transaction Tax’. Accessed 27 January 2015. http://www.msfaccess.org/our-work/malnutrition/article/1658.
  27. MSF. 2014a. ‘Issue Details: Access to Medicines’. Accessed 30 March 2015. http://www.msf.org.au/nc/about-msf/where-we-work/issue-details.html?tx_ttnews[issue]=1.
  28. MSF. 2014b. ‘MSF Intervention on Access to Medicines at WHO 134th Executive Board Meeting’. Accessed 24 January 2015. http://www.msfaccess.org/content/msf-intervention-access-medicines-who-134th-executive-board-meeting.
  29. Muzaka, Valbona. 2011. ‘Linkages, Contests and Overlaps in the Global Intellectual Property Rights Regime’. European Journal of International Relations 17(4): 755–76.CrossRefGoogle Scholar
  30. Nasu, Hitoshi. 2010. ‘Public Law Challenges to the Regulation of Pharmaceutical Patents in the US Bilateral Free Trade Agreements’. In Incentives for Global Public Health: Patent Law and Access to Essential Medicines, edited by Thomas Pogge, Matthew Rimmer, and Kim Rubenstein, 77–100. Cambridge: Cambridge University Press.CrossRefGoogle Scholar
  31. Novogrodsky, Noah Benjamin. 2010. ‘Beyond TRIPS: The Role of Non-State Actors and Access to Essential Medicines’. In Incentives for Global Public Health: Patent Law and Access to Essential Medicines, edited by Thomas Pogge, Matthew Rimmer, and Kim Rubenstein, 343–56. Cambridge: Cambridge University Press.CrossRefGoogle Scholar
  32. Peukert, Alexander. 2013. ‘Intellectual Property: The Global Spread of a Legal Concept’. Faculty of Law Research Paper 2. Frankfurt am Main: Goethe University.Google Scholar
  33. Pogge, Thomas, Matthew Rimmer, and Kim Rubenstein, eds. 2010. Incentives for Global Public Health: Patent Law and Access to Essential Medicines. Cambridge: Cambridge University Press.Google Scholar
  34. Quick, Jonathan, Hans V. Hogerzeil, Germán Velásquez, and Lembit Rägo. 2002. ‘Twenty-five Years of Essential Medicines’. Bulletin of the World Health Organization 80(11): 913–4.Google Scholar
  35. Risse, Thomas. 2000. ‘The Power of Norms versus the Norms of Power: Transnational Civil Society and Human Rights’. In The Third Force: The Rise of Transnational Civil Society, edited by Ann M. Florini, 177–209. Tokyo/Washington, DC: Japan Center for International Exchange/Carnegie Endowment for International Peace.Google Scholar
  36. Ryan, Michael P. 1998. Knowledge Diplomacy: Global Competition and the Politics of Intellectual Property. Washington, DC: Brookings Institution Press.Google Scholar
  37. Sandholtz, Wayne, and Kendall Stiles. 2008. International Norms and Cycles of Change. Oxford/New York: Oxford University Press.CrossRefGoogle Scholar
  38. Schaaber, Jörg. 2005. Keine Medikamente für die Armen? Hindernisse auf dem Weg zu einer gerechten Arzneimittelversorgung am Beispiel AIDS. Frankfurt am Main: Mabuse Verlag.Google Scholar
  39. Sell, Susan K. 1999. ‘Multinational Corporations as Agents of Change: The Globalization of Intellectual Property Rights’. In Private Authority and International Affairs, edited by A. Claire Cutler, Virginia Haufler, and Tony Porter, 169–97. Albany, NY: State University of New York Press.Google Scholar
  40. Sell, Susan K. 2003. Private Power, Public Law: The Globalization of Intellectual Property Rights. Cambridge: Cambridge University Press.CrossRefGoogle Scholar
  41. Sell, Susan K., and Aseem Prakash. 2004. ‘Using Ideas Strategically: The Contest Between Business and NGO Networks in Intellectual Property Rights’. International Studies Quarterly 48(1): 143–75.CrossRefGoogle Scholar
  42. Smyth, Alyna C. 2007. ‘Intellectual Property Rights and the Right to Health: Considering the Case of Access to Medicines’. In Ethics and Law of Intellectual Property: Current Problems in Politics, Science and Technology, edited by Christian Lenk, Nils Hoppe, and Roberto Andorno, 47–72. Aldershot: Ashgate.Google Scholar
  43. So, Anthony D., and Rachel Sachs. 2012. ‘Making Intellectual Property Work for Global Health’. Harvard International Law Journal 53: 106–43.Google Scholar
  44. Sykes, Alan O. 2002. ‘TRIPS, Pharmaceuticals, Developing Countries, and the Doha “Solution”’. John M. Olin Program in Law and Economics Working Paper 140. Chicago, IL: University of Chicago Law School.Google Scholar
  45. UN. 2000. ‘Security Council, Adopting ‘Historic’ Resolution 1308 on HIV AIDS, Calls for Pre-Deployment Testing, Counselling for Peacekeeping Personnel’. Press Release SC/6890, 17 July. Accessed 29 January 2015. www.un.org/News/Press/docs/2000/20000717.sc6890.doc.html.
  46. UNAIDS. 1999. Statement of the Joint United Nations Programme on HIV/AIDS (UNAIDS) at the Third WTO Ministerial Conference, Seattle, 30 November–3 December.Google Scholar
  47. UNDP. 2002. ‘Human Development Report 2002: Deepening Democracy in a Fragmented World’. Accessed 30 January 2015. http://hdr.undp.org/sites/default/files/reports/263/hdr_2002_en_complete.pdf.
  48. UNSC. 2000. ‘UN Security Council Resolution 1308 (2000) on the Responsibility of the Security Council in the Maintenance of International Peace and Security: HIV/AIDS and International Peace-keeping Operations’. Accessed 7 January 2015. http://data.unaids.org/pub/BaseDocument/2000/20000717_un_scresolution_1308_en.pdf.
  49. Watson, Alexandra G. 2009. ‘International Intellectual Property Rights: Do TRIPS’ Flexibilities Permit Sufficient Access to Affordable HIV/AIDS Medicines in Developing Countries?’. Boston College International and Comparative Law Review 32(1): 143–59.Google Scholar
  50. Welch, David. 1993. Justice and the Genesis of War. Cambridge: Cambridge University Press.CrossRefGoogle Scholar
  51. WHO. 1981. ‘Global Strategy for Health for All by the Year 2000’. Accessed 17 January 2015. http://whqlibdoc.who.int/publications/9241800038.pdf.
  52. WHO. 2006. ‘Public Health Innovation and Intellectual Property Rights: Report of the Commission on Intellectual Property Rights, Innovation and Public Health’. Accessed 20 January 2015. http://www.who.int/intellectualproperty/documents/thereport/ENPublicHealthReport.pdf?ua=1.
  53. WHO News. 2006. ‘Bulletin Interview: Do Patents Work for Public Health?—Interview with Carlos Correa’. Bulletin of the World Health Organization 84(5): 249–351. Accessed 12 February 2015. http://www.who.int/bulletin/volumes/84/5/who_news.pdf?ua=1.Google Scholar
  54. Wogart, Jan Peter, Gilberto Calcagnotto, Wolfgang Hein, and Christian von Soest. 2009. ‘AIDS and Access to Medicines: Brazil, South Africa and Global Health Governance’. In Making Sense of Global Health Governance: A Policy Perspective, edited by Kent Buse, Wolfgang Hein, and Nick Drager, 137–63. Houndmills: Palgrave Macmillan.Google Scholar
  55. Wolf, Klaus Dieter. 2008. ‘Emerging Patterns of Global Governance: The New Interplay between the State, Business and Civil Society’. In Handbook of Research on Global Corporate Citizenship, edited by Andreas Georg Scherer and Guido Palazzo, 225–48. Cheltenham: Edward Elgar Publishing.Google Scholar
  56. WTO. 1994. ‘Uruguay Round Agreement: TRIPS. Trade-Related Aspects of Intellectual Property Rights’. Accessed 7 February 2015. http://www.wto.org/english/docs_e/legal_e/27-trips_01_e.htm.
  57. WTO. 2001a. ‘Doha WTO Ministerial 2001: Declaration on the TRIPS Agreement and Public Health’. Accessed 15 February 2015. http://www.wto.org/english/thewto_e/minist_e/min01_e/mindecl_trips_e.htm.
  58. WTO. 2001b. ‘Doha WTO Ministerial 2001: Ministerial Declaration’. Accessed 7 January 2015. http://www.wto.org/english/thewto_e/minist_e/min01_e/mindecl_e.h.

Copyright information

© The Author(s) 2017

Authors and Affiliations

  1. 1.Peace Research Institute Frankfurt (PRIF)Frankfurt am MainGermany
  2. 2.Frankfurt School – UNEP Collaborating Centre for Climate & Sustainable Energy FinanceFrankfurt am MainGermany

Personalised recommendations